Prerequisites to Implementing a Pharmacogenomics Program in a Large Health‐Care System. Issue 3 (7th May 2014)

• Record Type: Journal Article
• Authors: Levy, K D; Decker, B S; Carpenter, J S; Flockhart, D A; Dexter, P R; Desta, Z; Skaar, T C
• Is Part Of: Clinical pharmacology & therapeutics. Volume 96:Issue 3(2014)
• Page Start: 307
• Page End: 309
• Publication Date: 2014-05-07
• Subjects: Pharmacology -- Periodicals; Therapeutics -- Periodicals; 615.5
• DOI: 10.1038/clpt.2014.101
• Languages: English
• ISSNs: 0009-9236

Abstract

<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Pharmacogenomics (PGx) technology is advancing rapidly; however, clinical adoption is lagging. The Indiana Institute of Personalized Medicine (IIPM) places a strong focus on translating PGx research into clinical practice. We describe what have been found to be the key requirements that must be delivered in order to ensure a successful and enduring PGx implementation within a large health‐care system.</p> <p> <italic>Clinical Pharmacology &amp; Therapeutics</italic> (2014); <bold>96</bold> 3, 307–309. advance online publication 11 June 2014. doi:<ext-link ext-link-type="doi" xlink:type="simple" xmlns:xlink="http://www.w3.org/1999/xlink">10.1038/clpt.2014.101</ext-link></p> </abstract>